Fabian Badtke heads the firm’s antitrust and competition group. He advises and represents national and international clients on all aspects of European and German antitrust law, including merger control and coordination of multi-jurisdictional filings, antitrust investigations, behavioural matters, antitrust litigation and compliance programmes. Fabian has particular industry know-how in the financial services, healthcare and life sciences, retail and media sectors.
Projects
DAF Trucks / Paccar in the defence against numerous antitrust damages claims brought before German courts
ICON on its $12bn acquisition of PRA Health Sciences
RIB Software on a €1.4bn public takeover bid by Schneider Electric
Fresenius/Helios: Advising on its €3bn acquisition of 40 hospitals and 13 medical care centres from Rhoen Klinikum
Fresenius Kabi on the implementation of a Europe-wide antitrust compliance program
ThyssenKrupp: Advising the company on its internal compliance investigations
ABN AMRO: Advising on the acquisition of Credit Suisse´s private banking business in Germany
Distinctions
Frequently recommended lawyer for antitrust law (JUVE Handbook, on-going since 2017; “really good, very pragmatic” (client), “ambitious and dedicated” (competitor))
Frequently recommended by GCR Competition Review in “Who’s Who Legal: Competition – Future Leaders” (“really impressive for merger filings” and also “well known for his strong antitrust practice, receiving international endorsements for his work on complex cartel damages claims”)
Recommended advisor for healthcare antitrust law (JUVE 2021/2022, "very satisfied, excellent lawyer in whom we have great confidence" (client))
Top lawyer for antitrust and competition, German business weekly WirtschaftsWoche (2021)
Frequently listed as an "antitrust Cartel law expert", " in Germany’s "Handelsblatt" newspaper
In 2008, he was awarded a prize for the best dissertation in competition law, corporate law and intellectual property rights by the Humboldt-University of Berlin
Career
Legal studies at the Universities of Potsdam and Cambridge, (UK) (LL.M.) and at the Humboldt-University of Berlin
Secondment to Deutsche Bank (2014)
Experience as a lawyer in a law firm specialising in medical law in Berlin
At Noerr since 2007
Admitted to the Berlin Chamber of Lawyers since 2006
Memberships
American Bar Association (ABA), Antitrust Section
Member of the antitrust research association Studienvereinigung Kartellrecht
KartellrechtsForum Frankfurt am Main
International Bar Association (IBA)
Lectures
Regular activity as moderator and speaker at the annual Noerr Competition Day
Regular live-webinars on antitrust litigation, antitrust compliance and distribution law
Publications
Antitrust in the financial services sector, Bankrecht, 6th ed. 2022, Carl Heymanns Verlag
Antitrust and R&D agreements, Verträge über Forschung und Entwicklung, 3rd ed. 2018, Carl Heymanns Verlag
Wer zahlt Kartellbußen? – Bundesarbeitsgericht zur Managerhaftung, Frankfurter Allgemeine Zeitung 28/06/2017, Recht und Steuern
Aktuelle Entwicklungen beim Akteneinsichtsrecht in Wettbewerbsverfahren (with Jan Moritz Lang), Wirtschaft und Wettbewerb (WuW 2016)
Should the Acquisition of Non-controlling Minority Shareholdings be Treated as Concentra-tions? (with Rea Diamantatou), Journal of European Competition Law & Practice, 2016, Vol. 7
Kollektive Marktbeherrschung im Kraftstoffmarkt? (with Dr Oliver Vahrenholt), Zeitschrift für Wettbewerbsrecht (ZWeR), 2012
Die Bedeutung des Kartellrechts bei M&A-Transaktionen, Kölner Schrift zum Wirtschaftsrecht (KSzW), 2011
Das Kartellrecht und die aktuelle Debatte um die Laufzeitverlängerung von Atomkraftwerken – eine kritische Würdigung (with Oliver Vahrenholt), Wettbewerb in Recht und Praxis (WRP) 2010
Der “Rhön-Beschluss” des BGH – endlich Klarheit bei der Zusammenschlusskontrolle von Krankenhausfusionen?, Zeitschrift für das gesamte Krankenhausrecht (KHR), 2008
Die Anwendbarkeit der deutschen und europäischen Fusionskontrolle auf Zusammenschlüsse von Krankenhäusern, Nomos Verlag, 2008
Die kartellrechtliche Bewertung des “AOK-Modells” beim Abschluss von Rabattverträgen, Wirtschaft und Wettbewerb (WuW), 2007
